Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch

Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch is a for-profit medical equipment manufacturer and supplier headquartered in Seoul, South Korea, registered with SAM.gov since September 29, 2016. The company specializes in providing advanced diagnostic equipment, reagents, and maintenance services to support U.S. military medical facilities throughout the Asia-Pacific region. Ortho-Clinical Diagnostics serves as a critical supplier of laboratory diagnostic systems and consumables to the Department of Defense, with a demonstrated track record of supporting military healthcare operations and medical readiness requirements at installations in South Korea, including Camp Humphreys and Osan Air Base.

The company has received multiple federal contract awards from the Defense Health Agency, Pacific Air Forces, and Army Medical Command totaling approximately $5.7 million in prime contract value. These awards encompass a diverse range of medical diagnostic products and services, including VITROS XT7600 chemistry and immunology analyzers, VITROS 500 reagents, maintenance and repair services for diagnostic equipment, and related laboratory supplies. Specific contract awards include a $2.66 million purchase order from the Defense Health Agency (July 1, 2023, through September 30, 2027) for chemistry and immunology analyzers and reagents at Brian D. Allgood Army Community Hospital; a $378,000 firm fixed-price purchase order from the Defense Health Agency (October 1, 2025, through September 30, 2030) for maintenance and repair services of an Ortho Vision Analyzer Blood Grouping System at the same facility; and a $116,040 purchase order from Pacific Air Forces (May 1, 2024, through April 30, 2029) for maintenance services on VITROS XT 7600 systems at Osan Air Base. Additional delivery orders under existing indefinite delivery vehicles include a $232,790 delivery order (October 1, 2025) for VITROS XT7600 reagents to the 51st Medical Group at Osan Air Base, a $600,000 delivery order (October 1, 2022, through September 30, 2023) for XT7600 reagents and analyzers at Camp Humphreys, and historical delivery orders from Army Medical Command valued at $200,000 and $600,000. None of these awards utilized set-aside designations, reflecting the company's status as a sole-source supplier for specialized diagnostic equipment and reagents compatible with existing military medical infrastructure.

Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch currently holds two prime indefinite delivery contracts. The first is a $1.25 million Indefinite Delivery Contract awarded by the Defense Health Agency on February 1, 2025, extending through September 30, 2026, for the supply of VITROS XT7600 reagents and consumables to support medical operations at U.S. military healthcare facilities in South Korea, particularly the 51st Medical Group at Osan Air Base. This single-award contract was established as a sole-source procurement under Federal Acquisition Regulation 13.501(a)(1)(ii), confirming that Ortho-Clinical Diagnostics represents the only viable source capable of meeting the specific technical and compatibility requirements for VITROS XT7600 reagent supplies. As of the current period, two delivery orders totaling approximately $360,802 have been issued against this IDV. The second indefinite delivery vehicle is a $900,000 Blanket Purchase Agreement awarded by Pacific Air Forces on September 1, 2021, with a last date to order of September 25, 2024, for the supply of VITROS 500 reagents to support diagnostic systems in South Korea. This single-award agreement generated at least one documented call of $113,536 issued on June 16, 2023, for VITROS 500 reagents through July 15, 2023. Both indefinite delivery contracts reflect the Defense Health Agency's and Pacific Air Forces' reliance on Ortho-Clinical Diagnostics as a specialized vendor for maintaining critical diagnostic capabilities across U.S. military medical installations in the Asia-Pacific region.